CING
Cingulate Inc.Company Information
- Company Name
- Cingulate Inc.
- CIK
- CIK0001862150
- Category
- Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
- Ticker: Exchange
- CING: Nasdaq, CINGW: Nasdaq
- Fiscal Year End
- December 31
- Owner Organization
- 03 Life Sciences
- SIC
- 2834
- SIC Description
- Pharmaceutical Preparations
- Ticker
- CING
SEC filing data through
Insider Sentiment
- Last purchase
- 2026-02-13
- Last sale
- 2024-08-15
- Shares purchased (TTM)
- 130,350
- Shares sold (TTM)
- 0
Institutional Sentiment
- As of
- 2026-06-30
- Institutional shares owned
- 1,817,794
- Shares outstanding
- 13,186,057
- Ownership
- 13.79%
Earnings Market Reaction
- Filing date
- 2026-08-13
- Price on filing date
- —
- 1-month reaction
- 2.20%
- 3-month reaction
- …
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets Current | ||||||||||||||||||
| Cash And Cash Equivalents At Carrying Value | 28 | 26 | 11 | 6 | 9 | 10 | 12 | 10 | 0 | 1 | 0 | 2 | ||||||
| Receivables Net Current | - | - | - | - | - | - | - | 0 | 2 | - | - | - | ||||||
| Other Receivables | - | - | - | 0 | 0 | 0 | - | - | - | - | - | - | ||||||
| Other Assets Miscellaneous Current | - | - | 0 | - | - | - | 0 | - | - | 0 | 0 | 0 | ||||||
| Other Receivables Net Current | 0 | 0 | - | - | - | - | - | - | - | - | - | - | ||||||
| Prepaid Expense And Other Assets Current | 2 | 2 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 2 | 1 | 1 | ||||||
| Assets Current | 30 | 28 | 12 | 7 | 10 | 11 | 13 | 11 | 3 | 3 | 1 | 3 | ||||||
| Property Plant And Equipment Net | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 3 | 3 | ||||||
| Operating Lease Right Of Use Asset | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Assets | 33 | 31 | 15 | 11 | 13 | 12 | 15 | 14 | 5 | 5 | 3 | 6 | ||||||
Liabilities Current | ||||||||||||||||||
| Accounts Payable Current | 2 | 3 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 5 | 2 | ||||||
| Accrued Liabilities Current | 1 | 2 | 2 | 2 | 1 | 1 | 1 | 0 | 0 | 1 | 2 | 1 | ||||||
| Notes Payable Current | 5 | 6 | 6 | 3 | 5 | 4 | 3 | - | - | - | 3 | 3 | ||||||
| Finance Lease Liability Current | - | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Operating Lease Liability Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Liabilities Current | 9 | 11 | 10 | 6 | 7 | 6 | 5 | 2 | 2 | 2 | 10 | 6 | ||||||
Liabilities Noncurrent | ||||||||||||||||||
| Finance Lease Liability Noncurrent | - | - | - | - | - | - | - | - | - | - | 0 | 0 | ||||||
| Long Term Notes Payable | - | - | 1 | - | - | 1 | 2 | - | - | - | - | - | ||||||
| Operating Lease Liability Noncurrent | 1 | 1 | 1 | 1 | 1 | - | - | - | - | 0 | 0 | 0 | ||||||
| Liabilities Noncurrent | 1 | 1 | 2 | 1 | 1 | 1 | 2 | - | - | 0 | 0 | 0 | ||||||
| Liabilities | 10 | 12 | 13 | 7 | 8 | 7 | 7 | 2 | 2 | 2 | 10 | 6 | ||||||
Stockholders Equity | ||||||||||||||||||
| Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Additional Paid In Capital | 171 | 161 | 135 | 130 | 123 | 118 | 117 | 114 | 102 | 99 | 86 | 86 | ||||||
| Retained Earnings Accumulated Deficit | -148 | -142 | -132 | -126 | -117 | -112 | -110 | -102 | -99 | -96 | -93 | -86 | ||||||
| Stockholders Equity | 23 | 19 | 3 | 3 | 6 | 6 | 7 | 12 | 3 | 3 | -7 | -0 | ||||||
| Liabilities And Stockholders Equity | 33 | 31 | 15 | 11 | 13 | 12 | 15 | 14 | 5 | 5 | 3 | 6 | ||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Common Stock Shares Authorized | 240 | 240 | 240 | 240 | 240 | 240 | 240 | 240 | - | 240 | 240 | 240 | ||||||
| Common Stock Shares Issued | 14 | 12 | 7 | 6 | 5 | 4 | 3 | 3 | 1 | 0 | 0 | 1 | ||||||
| Shares Outstanding | 14 | 12 | 7 | 6 | 5 | 4 | 3 | 3 | 1 | 0 | 0 | 1 | ||||||
| Preferred Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | - | 0.00 | 0.00 | 0.00 | ||||||
| Preferred Stock Shares Authorized | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | - | 10 | 10 | 10 | ||||||
| Preferred Stock Shares Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | 0 | 0 | 0 | ||||||
| Preferred Stock Shares Outstanding | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | 0 | 0 | 0 | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialCingulate Inc. (CING) — SEC Financial Statements & Analysis
Cingulate Inc. (CING) is a pharmaceutical preparations company, incorporated in DE. Cingulate Inc. trades on Nasdaq as: CING, CINGW. Cingulate Inc. (CING)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-13. Based on that filing, Cingulate Inc. carries a market cap of $72.13M, a P/E ratio of -2.50x, a P/B ratio of 3.07x, an enterprise value of $48.79M, and an EV/EBITDA multiple of -1.99x. On profitability, it posts a Return on Equity (ROE) of -198.74%, a Return on Assets (ROA) of -123.76%, and a Return on Invested Capital (ROIC) of -2654.38%. Per share, it reports EPS of $-2.18, diluted EPS of $-2.18, free cash flow per share of $-1.59, and a dividend per share of $0.00. Over the trailing year, it posted net income growth of 49.88% year-over-year and EPS growth of -50.11% year-over-year. On the balance sheet, it maintains a current ratio of 3.50x, a quick ratio of 3.30x, working capital of $21.58M, a debt-to-equity ratio of 0.41x, a debt ratio of 0.29, an interest coverage ratio of -36.75x, free cash flow of $-20.94M (TTM), and net debt of $-23.34M. Figures sourced from SEC EDGAR.
- Market Cap
- $72.13M
- P/E TTM
- -2.50x
- EPS TTM
- $-2.18
- P/B TTM
- 3.07x
- ROE TTM
- -198.74%
- ROA TTM
- -123.76%
- Debt To Equity
- 0.41x
- Free Cash Flow TTM
- $-20.94M
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is Cingulate Inc. in?
Cingulate Inc. (CING) operates in the Pharmaceutical Preparations industry.
What exchange does CING trade on?
Cingulate Inc. (CING) trades on the Nasdaq.
Where is Cingulate Inc. incorporated?
Cingulate Inc. is incorporated in DE.
When was Cingulate Inc. (CING)'s most recent SEC filing?
Cingulate Inc. (CING)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-13.
What is CING's market cap?
Cingulate Inc. (CING) has a market capitalization of $72.13M as of 2026-06-30.
What is CING's EPS (earnings per share)?
Cingulate Inc. (CING)'s trailing twelve month EPS is $-2.18 as of 2026-06-30.
What is CING's ROE (return on equity)?
Cingulate Inc. (CING)'s trailing twelve month Return on Equity (ROE) is -198.74% as of 2026-06-30.
What is CING's ROA (return on assets)?
Cingulate Inc. (CING)'s trailing twelve month Return on Assets (ROA) is -123.76% as of 2026-06-30.
What is CING's ROIC (return on invested capital)?
Cingulate Inc. (CING)'s trailing twelve month Return on Invested Capital (ROIC) is -2654.38% as of 2026-06-30.
What is CING's EV/EBITDA?
Cingulate Inc. (CING)'s trailing twelve month EV/EBITDA is -1.99x as of 2026-06-30.